TriaGen Wealth Management’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,165
Closed -$1.81M 165
2022
Q1
$1.81M Sell
20,165
-2,523
-11% -$222K 0.94% 41
2021
Q4
$2.01M Buy
+22,688
New +$1.82M 0.99% 28

Other funds holding CTSH

TriaGen Wealth Management's CTSH Position: Q2 2022 in Review

TriaGen Wealth Management sold out of Cognizant (CTSH) in Q2 2022, closing a stake of 20,165 shares — an estimated $1.81M sold.

TriaGen Wealth Management first reported a position in CTSH in Q4 2021 and held it in 2 quarters. The position peaked at $2.01M in Q4 2021. 916 funds tracked by Wall St. Rank hold CTSH as of Q2 2022.

  • TriaGen Wealth Management reported no remaining Cognizant position as of Q2 2022 after selling out during the quarter.
  • TriaGen Wealth Management sold 20,165 Cognizant shares in Q2 2022, an estimated $1.81M.
  • TriaGen Wealth Management first reported a position in Cognizant in Q4 2021 and held it in 2 quarters.
  • TriaGen Wealth Management's Cognizant position peaked at $2.01M in Q4 2021.
  • 916 funds tracked by Wall St. Rank held Cognizant as of Q2 2022.

Based on TriaGen Wealth Management's 13F filing for Q2 2022, filed 29 Jul 2022.